Betamethasone Dipropionate Patent Expiration
Betamethasone Dipropionate is Used for treating plaque psoriasis. It was first introduced by Schering Corp Sub Schering Plough Corp
Betamethasone Dipropionate Patents
Given below is the list of patents protecting Betamethasone Dipropionate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sernivo | US10179137 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
| Sernivo | US9364485 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
| Sernivo | US9433630 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
| Sernivo | US9439911 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
| Sernivo | US9655907 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
| Sernivo | US9775851 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
| Sernivo | US9877974 | Topical formulations comprising a steroid | Aug 31, 2030 | Primus Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Betamethasone Dipropionate's patents.
Latest Legal Activities on Betamethasone Dipropionate's Patents
Given below is the list recent legal activities going on the following patents of Betamethasone Dipropionate.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 06 Mar, 2024 | US9433630 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 14 Dec, 2023 | US9364485 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 15 Jul, 2022 | US10179137 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 30 Jul, 2021 | US9877974 |
| Email Notification | 26 Apr, 2021 | US10179137 |
| Change in Power of Attorney (May Include Associate POA) | 26 Apr, 2021 | US10179137 |
| Correspondence Address Change | 22 Apr, 2021 | US10179137 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 22 Apr, 2021 | US10179137 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 21 Apr, 2021 | US9877974 |
| Change in Power of Attorney (May Include Associate POA) | 21 Apr, 2021 | US9877974 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Betamethasone Dipropionate Generics
Several generic applications have been filed for Betamethasone Dipropionate. The first generic version for Betamethasone Dipropionate was by Actavis Mid Atlantic Llc and was approved on Jul 31, 1985. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Apr 10, 2024.
Given below is the list of companies who have filed for Betamethasone Dipropionate generic.
1. TARO
Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE
(reference standard) | lotion, augmented | Prescription | TOPICAL | AB | May 21, 2007 |
| EQ 0.05% BASE/SPRAY | spray | Discontinued | TOPICAL | N/A | Jun 17, 2020 |
2. ANDA REPOSITORY
Anda Repository Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Anda Repository.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | cream, augmented | Discontinued | TOPICAL | N/A | Jan 23, 2004 |
3. PERRIGO NEW YORK
Perrigo New York Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Perrigo New York.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | cream | Discontinued | TOPICAL | N/A | Nov 26, 1997 |
4. TEVA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | cream | Discontinued | TOPICAL | N/A | Aug 10, 1987 |
5. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | cream | Prescription | TOPICAL | AB | Oct 12, 2018 |
6. ALPHARMA US PHARMS
Alpharma Us Pharmaceuticals Division has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Alpharma Us Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | lotion | Discontinued | TOPICAL | N/A | Feb 3, 1987 |
7. SHREE HARI INTL
Shree Hari International Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Shree Hari Intl.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | lotion | Discontinued | TOPICAL | N/A | Aug 12, 1985 |
8. SAVAGE LABS
Savage Laboratories Inc Div Altana Inc has filed for 1 generic for Betamethasone Dipropionate. This eq 0.05% base version comes by the name ALPHATREX. Given below are the details of the strengths of this generic introduced by Savage Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | lotion | Discontinued | TOPICAL | N/A | Aug 12, 1985 |
9. ENCUBE
Encube Ethicals Private Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Encube.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | lotion, augmented | Discontinued | TOPICAL | N/A | Feb 13, 2018 |
10. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | lotion, augmented | Discontinued | TOPICAL | N/A | Oct 11, 2019 |
11. LUPIN LTD
Lupin Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | ointment, augmented | Prescription | TOPICAL | AB | Dec 18, 2019 |
12. FOUGERA PHARMS INC
Fougera Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE
(reference standard) | lotion | Prescription | TOPICAL | AB | Aug 12, 1985 |
13. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | cream | Prescription | TOPICAL | AB | Jan 11, 2019 |
14. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE
(reference standard) | cream, augmented | Prescription | TOPICAL | AB | Sep 23, 2008 |
15. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | lotion, augmented | Prescription | TOPICAL | AB | May 21, 2007 |
16. ACTAVIS MID ATLANTIC
Actavis Mid Atlantic Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | ointment, augmented | Prescription | TOPICAL | AB | Aug 31, 1995 |
17. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | ointment, augmented | Prescription | TOPICAL | AB | Apr 10, 2024 |
18. TASMAN PHARMA
Tasman Pharma Inc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Tasman Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | ointment | Prescription | TOPICAL | AB | Feb 18, 2022 |
19. PADAGIS US
Padagis Us Llc has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | ointment, augmented | Discontinued | TOPICAL | N/A | Nov 9, 2017 |
20. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | ointment | Prescription | TOPICAL | AB | Jul 14, 2020 |
21. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Betamethasone Dipropionate. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.05% BASE | ointment | Prescription | TOPICAL | AB | Apr 12, 2022 |